Literature DB >> 11602736

Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.

J L Dzuris1, J Sidney, H Horton, R Correa, D Carter, R W Chesnut, D I Watkins, A Sette.   

Abstract

Major histocompatibility complex class II molecules encoded by two common rhesus macaque alleles Mamu-DRB1*0406 and Mamu-DRB*w201 have been purified, and quantitative binding assays have been established. The structural requirements for peptide binding to each molecule were characterized by testing panels of single-substitution analogs of the two previously defined epitopes HIV Env242 (Mamu-DRB1*0406 restricted) and HIV Env482 (Mamu-DRB*w201 restricted). Anchor positions of both macaque DR molecules were spaced following a position 1 (P1), P4, P6, P7, and P9 pattern. The specific binding motif associated with each molecule was distinct, but largely overlapping, and was based on crucial roles of aromatic and/or hydrophobic residues at P1, P6, and P9. Based on these results, a tentative Mamu class II DR supermotif was defined. This pattern is remarkably similar to a previously defined human HLA-DR supermotif. Similarities in binding motifs between human HLA and macaque Mamu-DR molecules were further illustrated by testing a panel of more than 60 different single-substitution analogs of the HLA-DR-restricted HA 307-319 epitope for binding to Mamu-DRB*w201 and HLA-DRB1*0101. The Mamu-DRB1*0406 and -DRB*w201 binding capacity of a set of 311 overlapping peptides spanning the entire simian immunodeficiency virus (SIV) genome was also evaluated. Ten peptides capable of binding both molecules were identified, together with 19 DRB1*0406 and 43 DRB*w201 selective binders. The Mamu-DR supermotif was found to be present in about 75% of the good binders and in 50% of peptides binding with intermediate affinity but only in approximately 25% of the peptides which did not bind either Mamu class II molecule. Finally, using flow cytometric detection of antigen-induced intracellular gamma interferon, we identify a new CD4(+) T-lymphocyte epitope encoded within the Rev protein of SIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602736      PMCID: PMC114676          DOI: 10.1128/JVI.75.22.10958-10968.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.

Authors:  C J Pitcher; C Quittner; D M Peterson; M Connors; R A Koup; V C Maino; L J Picker
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 2.  The SIV-infected rhesus monkey model for HIV-associated dementia and implications for neurological diseases.

Authors:  D M Rausch; E A Murray; L E Eiden
Journal:  J Leukoc Biol       Date:  1999-04       Impact factor: 4.962

3.  Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.

Authors:  M A Ossevoort; J Ringers; E M Kuhn; L Boon; K Lorré; Y van den Hout; J A Bruijn; M de Boer; M Jonker; P de Waele
Journal:  Transplantation       Date:  1999-10-15       Impact factor: 4.939

4.  Several common HLA-DR types share largely overlapping peptide binding repertoires.

Authors:  S Southwood; J Sidney; A Kondo; M F del Guercio; E Appella; S Hoffman; R T Kubo; R W Chesnut; H M Grey; A Sette
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

5.  Recombinant modified vaccinia virus Ankara-simian immunodeficiency virus gag pol elicits cytotoxic T lymphocytes in rhesus monkeys detected by a major histocompatibility complex class I/peptide tetramer.

Authors:  A Seth; I Ourmanov; M J Kuroda; J E Schmitz; M W Carroll; L S Wyatt; B Moss; M A Forman; V M Hirsch; N L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 6.  Towards an HIV-1 vaccine: lessons from studies in macaque models.

Authors:  E G Hulskotte; A M Geretti; A D Osterhaus
Journal:  Vaccine       Date:  1998 May-Jun       Impact factor: 3.641

7.  Human class I supertypes and CTL repertoires extend to chimpanzees.

Authors:  R Bertoni; A Sette; J Sidney; L G Guidotti; M Shapiro; R Purcell; F V Chisari
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

8.  Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

Authors:  T M Allen; J Sidney; M F del Guercio; R L Glickman; G L Lensmeyer; D A Wiebe; R DeMars; C D Pauza; R P Johnson; A Sette; D I Watkins
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

9.  Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex.

Authors:  M J Kuroda; J E Schmitz; D H Barouch; A Craiu; T M Allen; A Sette; D I Watkins; M A Forman; N L Letvin
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Rapid effector function in CD8+ memory T cells.

Authors:  A Lalvani; R Brookes; S Hambleton; W J Britton; A V Hill; A J McMichael
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  17 in total

1.  Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques.

Authors:  Yongjun Sui; Qing Zhu; Susan Gagnon; Amiran Dzutsev; Masaki Terabe; Monica Vaccari; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Igor M Belyakov; Jay A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Comprehensive characterization of MHC class II haplotypes in Mauritian cynomolgus macaques.

Authors:  Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor
Journal:  Immunogenetics       Date:  2007-03-24       Impact factor: 2.846

3.  Selecting peptides to optimize Th1 responses to an equine lentivirus using HLA-DR binding motifs and defined HIV-1 Th peptides.

Authors:  Darrilyn G Fraser; Robert H Mealey; Travis C McGuire
Journal:  Immunogenetics       Date:  2003-08-27       Impact factor: 2.846

4.  Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors:  Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2013-04-23       Impact factor: 2.205

5.  Characterization of full-length MHC class II sequences in Indonesian and Vietnamese cynomolgus macaques.

Authors:  Hannah M Creager; Ericka A Becker; Kelly K Sandman; Julie A Karl; Simon M Lank; Benjamin N Bimber; Roger W Wiseman; Austin L Hughes; Shelby L O'Connor; David H O'Connor
Journal:  Immunogenetics       Date:  2011-05-26       Impact factor: 2.846

6.  TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.

Authors:  Yongjun Sui; Susan Gagnon; Amiran Dzutsev; Qing Zhu; Huifeng Yu; Alison Hogg; Yichuan Wang; Zheng Xia; Igor M Belyakov; David Venzon; Dennis Klinman; Warren Strober; Brian Kelsall; Genoveffa Franchini; Jay A Berzofsky
Journal:  Vaccine       Date:  2011-10-29       Impact factor: 3.641

7.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

8.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  DR*W201/P65 tetramer visualization of epitope-specific CD4 T-cell during M. tuberculosis infection and its resting memory pool after BCG vaccination.

Authors:  Huiyong Wei; Richard Wang; Zhuqing Yuan; Crystal Y Chen; Dan Huang; Lisa Halliday; Weihua Zhong; Gucheng Zeng; Yun Shen; Ling Shen; Yunqi Wang; Zheng W Chen
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

10.  Cellular Immune Response Induced by DNA Immunization of Mice with Drug Resistant Integrases of HIV-1 Clade A Offers Partial Protection against Growth and Metastatic Activity of Integrase-Expressing Adenocarcinoma Cells.

Authors:  Maria Isaguliants; Olga Krotova; Stefan Petkov; Juris Jansons; Ekaterina Bayurova; Dzeina Mezale; Ilze Fridrihsone; Athina Kilpelainen; Philip Podschwadt; Yulia Agapkina; Olga Smirnova; Linda Kostic; Mina Saleem; Oleg Latyshev; Olesja Eliseeva; Anastasia Malkova; Tatiana Gorodnicheva; Britta Wahren; Ilya Gordeychuk; Elizaveta Starodubova; Anastasia Latanova
Journal:  Microorganisms       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.